Ouellet, Daniele
Janssen Research & Development,
United States
2024 Rank: 264193
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2648 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 264193 | 288146 |
| Total Cites | 7474 | 8470 |
| H-index | 29 | 30 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 34 | 34 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 647 | 675 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 920 | 989 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5655 | 6199 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.37 |
| Self-Citation Percentage |
11.76%
|
|
Ouellet, Daniele
Janssen Research & Development,
United States
2023 Rank: 262030
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2691 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 262030 | 279470 |
| Total Cites | 7033 | 8007 |
| H-index | 27 | 30 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 32 | 32 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 616 | 644 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 857 | 925 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5304 | 5831 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.37 |
| Self-Citation Percentage |
12.16%
|
|
Ouellet, Daniele
Janssen Research & Development,
United States
2022 Rank: 257675
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2686 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 257675 | 281772 |
| Total Cites | 6415 | 7344 |
| H-index | 26 | 27 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 30 | 30 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 582 | 610 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 779 | 843 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4821 | 5322 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.38 |
| Self-Citation Percentage |
12.65%
|
|
Ouellet, Daniele
Janssen Research & Development,
United States
2021 Rank: 246845
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2610 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 246845 | 269850 |
| Total Cites | 6200 | 7107 |
| H-index | 26 | 27 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 30 | 30 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 572 | 600 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 755 | 815 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4642 | 5124 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.39 |
| Self-Citation Percentage |
12.76%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.